Prosecution Insights
Prosecution Insights
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §112 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PRONZATI, GINA | 1 | 66.7% | +41.7% |
| PARKIN, JEFFREY S | 1 | 63.5% | +21.4% |
| TINSLEY, BRENDAN THOMAS | 1 | 54.5% | +71.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18031494 | ASSAY FOR MEASURING POTENCY OF GENE THERAPY DRUG PRODUCT | PARKIN, JEFFREY S | 12d |
| 18273845 | MODULATION OF AAV-BASED GENE EXPRESSION | PRONZATI, GINA | 23d |
| 18020575 | GENE THERAPIES FOR LYSOSOMAL DISORDERS | TINSLEY, BRENDAN THOMAS | 76d |
| Art Unit | Apps |
|---|---|
| 1633 | 1 |
| 1671 | 1 |
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18273845 | MODULATION OF AAV-BASED GENE EXPRESSION | PRONZATI, GINA | 1633 | §103 | Non-Final OA | 23d | Pending | Jul 24, 2023 |
| 18031494 | ASSAY FOR MEASURING POTENCY OF GENE THERAPY DRUG PRODUCT | PARKIN, JEFFREY S | 1671 | §112 | Non-Final OA | 12d | Pending | Apr 12, 2023 |
| 18020575 | GENE THERAPIES FOR LYSOSOMAL DISORDERS | TINSLEY, BRENDAN THOMAS | 1634 | DPOther | Final Rejection | 76d | Pending | Feb 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial